Patient Trust in AI: What Healthcare Security Leaders Must Do About AI Transparency and Governance in 2026

A recent survey covered by The HIPAA Journal confirms what many of us in healthcare security have been warning clients about for the past two years: patients are paying attention to how artificial intelligence is used in their care, and they want answers. Patients are concerned about AI tools deployed by doctors' offices and other covered entities, and they expect transparency about when and how these tools influence their diagnosis, treatment, and the handling of their protected health information (PHI).

This is not a soft PR issue. From a defender's seat, patient concern about AI translates directly into three hard operational risks:

Regulatory exposure — AI systems that ingest, process, or generate PHI without proper safeguards create HIPAA Security Rule and Privacy Rule violations waiting to be discovered by OCR.
Shadow AI proliferation — Clinicians adopting unsanctioned AI tools (transcription assistants, diagnostic aids, ambient scribes) outside IT's visibility is now one of the fastest-growing data leakage vectors in healthcare.
Expanded attack surface — Every AI vendor, API integration, and cloud inference endpoint touching ePHI is a new third-party risk and a new entry in your supply-chain threat model.

Healthcare organizations that treat AI governance as a compliance checkbox will fail both regulators and patients. Those that build defensible, documented, patient-transparent AI programs will turn this concern into a competitive trust advantage.

Why This Survey Matters to Security Teams

The survey's core finding — patients want to know when and how AI is used in their healthcare — has direct security architecture implications:

You cannot disclose what you cannot inventory. If your organization cannot produce a complete list of AI-enabled systems processing PHI (including embedded AI features in EHR platforms, billing software, and radiology PACS), you cannot honor patient transparency expectations or satisfy a HIPAA risk analysis.
Business Associate Agreements are lagging behind AI adoption. Many AI features ship as automatic updates inside existing vendor products. If your BAA predates the vendor's AI rollout, the terms covering data use, model training on patient data, and subprocessor disclosure may be silently out of scope.
Patient trust failures become breach-notification events. An undisclosed AI tool that mishandles PHI isn't just a privacy complaint — under the HIPAA Breach Notification Rule, impermissible disclosure to an AI vendor without a BAA can constitute a reportable breach affecting thousands of patients.

In my IR work, the pattern is consistent: the organizations blindsided by AI-related privacy incidents are the ones where security learned about the AI deployment after procurement, after go-live, and sometimes after the OCR complaint.

Executive Takeaways

1. Build and Maintain an Authoritative AI System Inventory

Create a mandatory registry of every AI or machine-learning capability that creates, receives, maintains, or transmits ePHI. Include:

Embedded AI features in existing platforms (EHR decision support, ambient documentation, coding automation)
Standalone AI tools adopted by clinical or administrative staff
AI capabilities delivered via third-party APIs and SaaS integrations

Enforce a policy that no AI tool touches PHI without security review and inventory registration. Make shadow AI discovery a standing hunt objective — review SaaS spend, CASB logs, and OAuth grant audits quarterly.

2. Update BAAs and Vendor Contracts for the AI Era

Work with legal counsel to ensure every BAA explicitly addresses:

Whether patient data is used to train or fine-tune vendor models (and the right to prohibit it)
Data retention, deletion, and geographic processing locations for AI workloads
Subprocessor disclosure when the vendor chains to foundation-model providers (e.g., a scribe vendor routing audio to a third-party LLM API)
Breach notification timelines specific to AI pipeline compromises

Audit your existing BAA portfolio against current vendor AI features — do not assume last year's contract covers this year's product update.

3. Integrate AI into Your HIPAA Risk Analysis

The HIPAA Security Rule requires an accurate and thorough risk analysis of ePHI confidentiality, integrity, and availability. Extend it to cover AI-specific threat scenarios:

Prompt injection or model manipulation altering clinical decision support output (an integrity risk to patient safety)
PHI leakage through prompts, logs, or telemetry sent to external model endpoints
Membership inference and data extraction risks from models fine-tuned on patient data
Availability risks if clinical workflows become dependent on an AI service that fails or is ransomed

Document these in your risk register with owners and remediation dates — OCR investigators increasingly ask for exactly this.

4. Establish Patient-Facing AI Transparency Controls

Translate the survey finding into policy:

Update your Notice of Privacy Practices (NPP) to describe categories of AI use in care delivery and operations
Define where patient consent or opt-out mechanisms apply, consistent with state law (several states are moving on AI-in-healthcare disclosure requirements)
Train front-desk and clinical staff to answer patient questions about AI accurately — a confused answer at intake is a trust incident

Transparency here is not just ethics; it reduces complaint-driven regulatory scrutiny.

5. Apply Technical Safeguards to AI Data Flows

Treat AI pipelines with the same rigor as any ePHI system:

Enforce encryption in transit and at rest for all AI data flows, including API calls to inference endpoints
Apply role-based access controls and minimum-necessary scoping to training datasets and prompt logs
Log and monitor AI API usage; alert on anomalous volume or destinations consistent with data exfiltration
Segment AI workloads so a compromised inference service cannot pivot into the EHR or clinical network

6. Prepare an AI-Specific Incident Response Playbook

Extend your IR plan with scenarios unique to AI systems: model compromise, PHI exposure via a vendor's AI pipeline, and manipulated AI output affecting patient care. Define evidence preservation steps (prompt logs, model versions, API request records) and decision trees for when an AI incident triggers HIPAA breach notification. Tabletop these scenarios with clinical leadership, not just IT — the patient-safety dimension changes escalation thresholds.

The Bottom Line

This survey is a leading indicator. Patients are telling the industry — and by extension, regulators — that undisclosed AI use in healthcare is unacceptable. For security leaders, the mandate is clear: inventory every AI capability touching PHI, close the contractual and risk-analysis gaps, monitor AI data flows like any other exfiltration path, and build transparency into patient-facing policy before an incident or an OCR investigation forces the issue.

The organizations that get ahead of this now will be the ones whose AI programs survive regulatory scrutiny and earn patient trust. The rest will be explaining themselves in a breach notification letter.

Related Resources

Security Arsenal Healthcare Cybersecurity AlertMonitor Platform Book a SOC Assessment healthcare Intel Hub